Streetbeat News

Stock Prices

RDHL

Shares of Redhill Biopharma (RDHL) were halted on a circuit breaker due to a sharp increase in price, with the stock surging 71%. Circuit breakers are designed to prevent excessive volatility and allow traders to assess the situation.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:43 pm

CAAS

CROX

LAD

MDC

VSCO

Benzinga Insights has identified five value stocks in the consumer cyclical sector based on low P/E ratios, which suggest they may be undervalued. The stocks include Crocs (CROX), Victoria's Secret (VSCO), China Automotive Systems (CAAS), M.D.C. Holdings (MDC), and Lithia Motors (LAD). The article provides recent earnings per share (EPS) data and dividend yield changes for these companies, indicating their financial performance and potential investor returns.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:43 pm

AFRM

Affirm Holdings Inc (NASDAQ:AFRM) experienced volatility after a 12% rise on Monday, likely due to heavy 'Buy Now, Pay Later' usage reported on Cyber Monday. U.S. Cyber Monday sales reached a record $12.4 billion, with 'Buy Now, Pay Later' transactions totaling $940 million, up 42.5% year-over-year. Jefferies analyst John Hecht upgraded Affirm from Underperform to Hold and increased the price target from $9.50 to $30. Affirm's stock was slightly down at $29.26 at the time of publication.

Portfolio Pulse from Adam Eckert

November 28, 2023 | 2:41 pm

ARW

CSIQ

MVLA

OCC

SURG

Benzinga Insights has identified five value stocks in the technology sector based on their low price-to-earnings (P/E) multiples, suggesting they may be undervalued. The stocks are Optical Cable (OCC), Arrow Electronics (ARW), Movella Holdings (MVLA), Canadian Solar (CSIQ), and Surgepays (SURG). The article provides recent earnings per share (EPS) data and dividend yield for these companies, noting changes from previous quarters.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 2:40 pm

DRCT

Direct Digital Holdings shares have resumed trading. There is no additional context provided regarding the reason for the trading halt or the implications of the resumption.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:40 pm

CWEN

GDEV

LASR

PDD

RNA

SWTX

PDD Holdings Inc. reported a significant year-on-year revenue growth of 94% in Q3 FY23, surpassing consensus estimates, with shares surging 18.6%. Avidity Biosciences, SpringWorks Therapeutics, and other companies also saw their stocks move higher. Avidity expanded its collaboration with Bristol Myers Squibb, SpringWorks received FDA approval for Ogsiveo, and other companies experienced various positive catalysts including upgrades, inclusion in indices, and favorable analyst coverage.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 2:39 pm

BTCUSD

ETHUSD

FTTUSD

LUNCUSD

Cryptocurrency prices fluctuated with Bitcoin and Ethereum remaining above key levels of $37,000 and $2,000 respectively. FTX Token was the top gainer, while Terra Classic was the biggest loser in the last 24 hours. The global crypto market cap declined by 1.4% to $1.4 trillion. Other notable gainers include Celestia, Toncoin, Oasis Network, and Uniswap, while The Graph, Blur, Gala, and Theta Network were among the losers.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 2:38 pm

LEXX

Lexaria Bioscience reported interim results from a human pilot study evaluating its DehydraTECH technology for oral delivery of semaglutide, a drug found in Rybelsus. The study showed that DehydraTECH-powered semaglutide sustained lower blood glucose levels, including nearly 10 times lower after 24 hours, and reduced blood-glucose spikes after eating. This marks the first successful DehydraTECH test with a large molecule drug.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:36 pm

ANIK

Anika Therapeutics, Inc. (NASDAQ:ANIK) announced the first successful surgeries using its Integrity Implant System for rotator cuff repairs, marking its entry into the $150 million+ U.S. rotator cuff augmentation market. The FDA-cleared system includes a hyaluronic acid-based scaffold and is part of Anika's expanding regenerative product portfolio. The limited market release of Integrity is ahead of schedule, with a full market release expected in Q1 2024. The system is designed to promote healing and has shown superior results compared to the leading collagen implant in an animal study. Anika's comprehensive rotator cuff solution portfolio positions the company as a key player in orthopedic regenerative solutions and sports medicine.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:36 pm

DRCT

Shares of Direct Digital Holdings were halted due to a circuit breaker after falling 15.3%. This indicates a significant drop in the company's stock price, triggering a temporary pause in trading to prevent further immediate decline.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:35 pm